Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
270 Ergebnisse für "cardiac" unter Roche Glycart AG
Cardiac
... Cardiovascular disease and cardiac biomarkers We help improve people’s lives by maximizing ... . We help improve people’s lives by maximizing confidence in decision making in cardiac through ... Cardiac ... Cardiac Det verkar som att du använder inkognito mode/privat surfningsläge eller en ... Cardiac ...
Roche Cardiac
... Roche Cardiac ... Roche Cardiac Il nostro impegno Il valore della sostenibilità Pionieri sempre Patologie Scompenso ... Roche Cardiac ...
Dinaqor
8952 Schlieren, Wagistrasse 25
DiNAQOR’s mission is to develop gene therapy solutions that transform the lives of patients with heart disease. Our novel and innovative gene therapy platform is focused on advancing treatments for patients affected by genetic cardiomyopathies, a disease of the heart muscle that can lead to heart failure.
Dinaqor
Wagistrasse 25
8952 Schlieren
115 Ergebnisse für "cardiac" unter Dinaqor
Cardiac Specific Expression – DiNAQOR
... Cardiac Specific Expression Cardiac Specific Expression A highly heart-specific human cardiac ... expressed in cardiac tissue. Driving strong gene expression in a heart-specific manner enables efficacy and ... Cardiac Specific Expression – DiNAQOR ... https://www.dinaqor.com/platform/ cardiac-specific-expression/ ... Cardiac Specific Expression – DiNAQOR ...
Cardiac Specific Expression – DiNAQOR
... Cardiac Specific Expression Cardiac Specific Expression A highly heart-specific human cardiac ... expressed in cardiac tissue. Driving strong gene expression in a heart-specific manner enables efficacy and ... Cardiac Specific Expression – DiNAQOR ... http://www.dinaqor.com/platform/ cardiac-specific-expression/ ... Cardiac Specific Expression – DiNAQOR ...
University Hospital Zurich, Research and Education Office
https://www.usz.ch/forschung/Seiten/default.aspx
8091 Zürich, Rämistrasse 100
The University Hospital Zurich is one of Switzerland’s largest hospitals and a pioneering institution in the field of clinical research. In its 40 departments and institutes, it assembles and practices all medical disciplines and enjoys an excellent reputation for state-of-the-art medicine, professional and com- passionate patient care, and groundbreaking bench-to-bedside translational medical research.
University Hospital Zurich, Research and Education Office
Rämistrasse 100
8091 Zürich
418 Ergebnisse für "cardiac" unter University Hospital Zurich, Research and Education Office
Cardiac amyloidosis: still challenging
... Cardiac amyloidosis: still challenging CARDIOVASCULAR FLASHLIGHT ... . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . doi:10.1093/eurheartj/ehw290 Cardiac amyloidosis: still challenging Natallia Laptseva1, Michel Zuber2 ... Cardiac amyloidosis: still challenging ... Cardiac amyloidosis: still challenging CARDIOVASCULAR FLASHLIGHT ... Cardiac amyloidosis: still challenging ...
Department of Cardiac Surgery – USZ
... Contact form Today, modern cardiac surgery means that the treating surgeon tailors the therapy to ... and cardiac surgery work together, weigh up all the options with the patient and plan the optimal ... Department of Cardiac Surgery – USZ ... https://www.usz.ch/en/clinic/ cardiac-surgery/ ... Department of Cardiac Surgery – USZ ...
Somagenetix
https://www.wysszurich.ch/projects/somagenetix
8952 Schlieren, Wagistrasse 23
Gene therapy solutions for patients with severe inherited diseases.
Somagenetix
Wagistrasse 23
8952 Schlieren
859 Ergebnisse für "cardiac" unter Somagenetix
Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac S...
... prevent or treat low cardiac output syndrome. We sought to compare efficacy and safety of these drugs in ... . SETTING: Tertiary-care university children's hospital postoperative pediatric cardiac ICU. PATIENTS: After ... Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind ... Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind ... Prevention of Low Cardiac Output Syndrome After Pediatric Cardiac Surgery: A Double-Blind ...
Continuous, non-invasive techniques to determine cardiac output in ...
... Copy Abstract BACKGROUND: Continuous and non-invasive measurement of cardiac output (CO) may ... ). METHODS/MATERIAL: In 26 infants and children who had undergone corrective cardiac surgery at a median age ... Continuous, non-invasive techniques to determine cardiac output in children after cardiac surgery ... Continuous, non-invasive techniques to determine cardiac output in children after cardiac surgery ... Continuous, non-invasive techniques to determine cardiac output in children after cardiac surgery ...
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
51 Ergebnisse für "cardiac" unter ETH Entrepreneurship
Extracting Cardiac Information From Medical Radar Using Locally Pro...
... Extracting Cardiac Information From Medical Radar Using Locally Projective Adaptive Signal ... : Yao Y, Sun G, Kirimoto T and Schiek M (2019) Extracting Cardiac Information From Medical Radar Using ... Extracting Cardiac Information From Medical Radar Using Locally Projective Adaptive Signal ... Extracting Cardiac Information From Medical Radar Using Locally Projective Adaptive Signal ... Extracting Cardiac Information From Medical Radar Using Locally Projective Adaptive Signal ...
Predicting cardiac remodeling after myocardial infarction with mach...
... cardiac remodeling after myocardial infarction with machine learning: are we there yet? ... Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet? - ... Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet ... Predicting cardiac remodeling after myocardial infarction with machine learning: are we there yet? - ...
University of Zurich
https://www.campus-schlieren.uzh.ch/en.html
8952 Schlieren, Wagistrasse 12
The University of Zurich (UZH) is Switzerland’s largest university, with seven faculties and a current enrollment of over 26,000 students. More than 5,000 highly qualified members of the teaching staff, including some 580 professors, teach and conduct research at the 150 University institutes. In the field of life sciences, the University of Zurich is well known for its groundbreaking research in medicine, immunology, neuroscience, and structural biology. In the interest of serving the community, the University of Zurich promotes the transfer of research-based knowledge to private enterprise, and our spin-off ventures and business partnerships regularly lead to the creation of attractive jobs in innovative fields.
University of Zurich
Wagistrasse 12
8952 Schlieren
276 Ergebnisse für "cardiac" unter University of Zurich
Items where Subject is "04 Faculty of Medicine > University Hospita...
... Items where Subject is "04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiac ... Items where Subject is "04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiac ... Items where Subject is "04 Faculty of Medicine > University Hospital Zurich > Clinic for Cardiac ...
Extracellular matrix for reconstruction of cardiac structures after...
... atrial reconstruction in patients with cardiac tumours. METHODS: A new extracellular matrix patch was ... of a primary cardiac sarcoma. In a third case, it was used to reconstruct both atria, the right-sided ... Extracellular matrix for reconstruction of cardiac structures after tumour resections - Zurich Open ... Extracellular matrix for reconstruction of cardiac structures after tumour resections - Zurich Open ... Extracellular matrix for reconstruction of cardiac structures after tumour resections - Zurich Open ...
Dualsystems Biotech AG
8952 Schlieren, Grabenstrasse 11a
+41 44 738 50 00
info@dualsystems.com
Dualsystems Biotech is a provider of proteomics services for industry and academia.
Dualsystems Biotech AG
Grabenstrasse 11a
8952 Schlieren
22 Ergebnisse für "cardiac" unter Dualsystems Biotech AG
Publications – Dualsystems Biotech AG
... interactions by Flow‑TriCEPS Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution ... interactions by Flow‑TriCEPS Cardiac Targeting Peptide, a Novel Cardiac Vector: Studies in Bio-Distribution ...
InSphero AG
8952 Schlieren, Wagistrasse 27
+41 44 515049-0
info@insphero.com
InSphero is a leading supplier of organotypic, biological in vitro 3D microtissues for highly predictive drug testing. The company currently counts all of the top ten global pharmaceutical and cosmetics companies as customers and is helping them to implement its patented microtissue technology in their development work-flow.
InSphero AG
Wagistrasse 27
8952 Schlieren
30 Ergebnisse für "cardiac" unter InSphero AG
Insphero
... San Antonio, TX, demonstrating that cardiac microtissues composed of iPSC derived cardiomyocytes ... cardiac microtissues as an ideal in vitro model for the study of acute and chronic toxicity. ... San Antonio, TX, demonstrating that cardiac microtissues composed of iPSC derived cardiomyocytes ... cardiac microtissues as an ideal in vitro model for the study of acute and chronic toxicity. More details ...
Insphero
... beyond the liver with 3D pseudoislet , brain, cardiac, and skin microtissue models See how our 3D-focused ... beyond the liver with 3D pseudoislet , brain, cardiac, and skin microtissue models See how our 3D-focused ...
Swiss Bioscience GmbH
https://www.swissbioscience.com/
8952 Schlieren, Wagistrasse 27a
+41 (0) 44 731 99 00
info@swissbioscience.com
Swiss Bioscience GmbH manufactures and banks stem cells for individuals and provides pharmaceutical grade SVF* and hADSCs** produced under cGMP*** conditions. (* Stromal Vascular Fraction extracted from human lipoaspirate, ** Human Adipose Tissue Derived Stem Cells, *** Current Good Manufacturing Practice)
Swiss Bioscience GmbH
Wagistrasse 27a
8952 Schlieren
2 Ergebnisse für "cardiac" unter Swiss Bioscience GmbH
SBS | Cardiovascular Diseases
... cardiac function and angiogenesis after stem cell transplantation. While some clinical trials are ... cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell ... improvements in cardiac function and angiogenesis after stem cell transplantation. While some clinical trials ... cells in cardiac regeneration: a detailed progress report of the last 6 years (2010–2015). Stem Cell ...
SBS | Application for hADSCs
... Experimental results have exhibited significant improvements in cardiac function and angiogenesis after stem ...
CSL Vifor
https://www.csl.com/we-are-csl/our-businesses-and-products/csl-vifor
8952 Schlieren, Zürcherstrasse 39D
+41 58 851 80 00
Pioneer in iron-based therapies, CSL Vifor is a global leader in iron deficiency and iron deficiency anaemia therapies, with a history dating back to 1872, when pharmacist Caspar Friedrich Hausmann opened a pharmacy in St. Gallen, Switzerland. Since then, we have proven our ability to identify and serve therapeutic areas and patients with significant unmet medical need. Building on our heritage and expertise in iron deficiency therapy, and together with our joint company Vifor Fresenius Medical Care Renal Pharma, today we have a strong and rapidly growing presence in nephrology, and we are committed to launching the next generation of therapies to truly address the full spectrum of kidney disease.
CSL Vifor
Zürcherstrasse 39D
8952 Schlieren
7 Ergebnisse für "cardiac" unter CSL Vifor
CSl Vifor Ireland Report_EN_19062029_FINAL.xlsx
... Ireland Cardiac Newcastle Ireland Thomas Hynes Road, GL2D-NEW N/A 14705.88 € 14705.88 € Gastroenterology ... Croi House, Moyola Lane, GAL1-NEW N/A 45000.00 € 45000.00 € 90000.00 € Irish Cardiac Society Dublin 6 ... Ireland Cardiac Newcastle Ireland Thomas Hynes Road, GL2D-NEW N/A 14705.88 € 14705.88 € Gastroenterology ... Croi House, Moyola Lane, GAL1-NEW N/A 45000.00 € 45000.00 € 90000.00 € Irish Cardiac Society Dublin 6 ...
CSL Annual Report 2022 – Page 14
... inherited respiratory disease. CSL Behring’s products are also used in cardiac surgery, for burns treatment ... also used in cardiac surgery, for burns treatment and for urgent warfarin reversal. Immunology Our ...
